When must an event be reported externally?

Reporting obligations depend on product type and regulatory rules; evaluate seriousness and causality and follow applicable FDA or other regulator timelines for reportable events.

Can electronic records and signatures be used?

Yes; electronic records and signatures are generally enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided intent, consent, attribution, and retention requirements are met.

How should PHI be protected in surveillance data?

Treat protected health information under HIPAA controls, implement BAAs when vendors handle PHI, and apply access controls, encryption, and minimum necessary principles.

Is notarization ever required?

Notarization is rarely required for routine surveillance records but may be needed for legal declarations or affidavits; follow state rules for notarization and RON where used.

What if a record needs correction after submission?

Document revisions with version control and approved change control; notify regulators as required and retain prior versions per retention policy.

How long must surveillance records be retained?

Retention depends on applicable rules; follow HIPAA (45 CFR §164.530(j)) and other federal or contractual requirements and retain records for the longest applicable period.

Electronic Signature
Templates
Healthcare
Healthcare Post Market Surveillance

Healthcare Post Market Surveillance

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE POST MARKET SURVEILLANCE REPORT

Use this form to report post-market events involving a medical device or healthcare product for the purpose of surveillance, trending, corrective action, and regulatory reporting. Provide as much detail as possible. Information collected may include protected health information and will be used in accordance with applicable privacy law and the manufacturer’s surveillance program.

Reporter Information

Reporter Type

Patient Healthcare Professional Manufacturer Representative Other

Reporter Full Name Organization / Facility

Phone

Email

Reporter Address

Patient Information

Patient Full Name

Date of Birth

Gender Male Female Other

Patient Address

Patient Phone

Emergency Contact

Emergency Phone

Insurance Information (if applicable)

Insurance Provider

Policy Number

Group Number

Subscriber Name

Device / Product Information

Product Name

Model / Reference

Catalog Number

Lot / Batch

Serial Number

Manufacturer

Implant / First use date: Place of use:

Event Details

Event date: Event time:

Event Type (select all that apply)

Adverse Event Malfunction Complaint Near Miss Other

Place where event occurred Detailed Description of Event Immediate clinical outcome Seriousness indicators (check all that apply)

Hospitalization or prolongation of hospitalization Life-threatening Death Persistent or significant disability/incapacity

Medical History & Concomitant Factors

Current Medications Allergies Relevant Medical History / Chronic Conditions Concomitant Devices or Therapies

Investigation & Corrective Actions

Actions Taken at Time of Event

Device returned to manufacturer for analysis If yes, tracking/reference:

Lot/batch quarantined Reference or disposition:

Recommended or Planned Corrective Actions

Follow-up requested from manufacturer: If follow-up requested, preferred contact method:

Attachments & Evidence

Attached Materials

Photos Returned Device Clinical Reports Other

Attachment Details

Authorization, Confidentiality & Certification

By completing and signing this report, the signer authorizes the manufacturer and its authorized agents to collect and retain the information provided herein, including protected health information as necessary for safety surveillance, investigation, and regulatory reporting. The signer authorizes contact with treating clinicians and facilities for follow-up and investigation, and the release of relevant medical records limited to the circumstances of this event.

This authorization is voluntary but may be necessary for the manufacturer to assess product safety. The signer may withdraw authorization in writing; withdrawal will not apply to information already disclosed pursuant to this authorization or to records retained to meet regulatory obligations. Information will be retained and processed consistent with applicable law and the manufacturer’s surveillance procedures.

Certification: I certify that the information provided in this report is true, accurate, and complete to the best of my knowledge. I understand that knowingly providing false information may be subject to penalties under applicable law.

Authorization expiration date (if different from default program retention):

Acknowledgment of privacy notice: I acknowledge that I have been informed of how my data will be used for post-market surveillance and safety investigation purposes.

Additional Comments

Patient Printed Name:

Signature:

Date:

If signing on behalf of patient, Relationship to patient:

Signer Printed Name (if not patient):

What Healthcare Post Market Surveillance Means

Healthcare Post Market Surveillance is the ongoing collection, monitoring, and analysis of safety, performance, and real‑world data for a marketed medical product, device, or health technology. It includes adverse event collection, trend analysis, signal detection, corrective actions, and regulatory reporting to demonstrate continued safety and effectiveness. Surveillance activities support risk management, labeling updates, and product lifecycle decisions while preserving patient privacy and complying with federal and applicable state requirements.

Why a Structured Post Market Surveillance Program Matters

A documented surveillance program reduces patient safety risk, supports regulatory compliance, and helps manufacturers detect trends, justify labeling changes, and implement timely corrective actions.

Who Completes Healthcare Post Market Surveillance Activities

Roles vary by organization size; smaller companies often combine responsibilities across fewer staff while larger firms use dedicated specialists and documented workflows.

Regulatory Affairs teams coordinate reporting to FDA and other regulators and maintain submission records.
Clinical Safety teams aggregate adverse events, perform signal detection, and document risk assessments.
Quality Assurance groups track corrective actions, CAPAs, and documentation for audits and inspections.

Core Components of a Professional Surveillance Record

A complete post market surveillance record organizes evidence and actions so reviewers can understand data sources, analyses, and decisions. The following elements form the structural backbone of a defensible program.

Device Identification

Catalog device model, version, UDI/lot numbers, and distribution scope to link events to specific products and manufacturing lots.

Data Sources

List active and passive sources: complaints, electronic health records, registries, literature, social media monitoring, and investigational follow‑up.

Signal Detection

Describe methods, thresholds, and statistical approaches used to detect safety signals and unusual event clusters.

Risk Assessment

Record clinical impact assessments, root cause hypotheses, severity/likelihood ratings, and benefit‑risk conclusions for observed signals.

Corrective Actions

Document CAPAs, design changes, labeling updates, distribution holds, and timelines for implementation and verification.

Regulatory Reporting

Track reportable events, report destinations, submission dates, and supporting documentation retained for inspection.

Stepwise Process to Complete a Surveillance Report

Follow a consistent sequence to assemble a surveillance record that is auditable and defensible during regulatory review.

01

Collect Data: Gather event reports, clinical data, and literature relevant to the product.
02

Verify Events: Confirm event legitimacy, device identification, and patient outcomes where possible.
03

Analyze Trends: Run signal detection and clinical review to identify patterns and causality indicators.
04

Document Actions: Record risk assessments, CAPAs, communications, and regulatory submissions with dates.

Configuring the Online Surveillance Workflow

A clear digital workflow reduces delays and preserves an audit trail. Configure these settings to match your internal processes.

Field	Configuration
Authentication	Use email plus optional MFA or organization SSO for sensitive submissions
Template	Create a reusable template with mandatory fields and conditional logic
Notifications	Auto‑route alerts to regulatory, quality, and clinical reviewers
Retention Policy	Set automatic retention periods and export options for audits

Typical Digital Flow for Submitting and Reviewing Reports

Digital submission streamlines intake, review, and reporting while capturing timestamps and an audit trail for each action.

Submit Report: Reporter uploads documents and completes required fields via form.
Triage: Automated rules route the report to appropriate reviewers.
Clinical Review: Safety team assesses seriousness and potential causality.
Regulatory Action: Prepare any required external submissions and CAPA follow‑up.

Technical and Integration Considerations

Choose a platform that supports secure uploads, audit trails, and integrations with your existing systems.

Integrations: Salesforce, NetSuite, Microsoft 365, Google Workspace
File Formats: PDF, DOCX, XLSX, XML supported
Audit Trail: Detailed logs, timestamps, and signer metadata

Export, Archival, and Supporting Documents to Include

Prepare export packages that combine signed reports, source documents, and an audit trail for inspections or regulatory submissions.

Export Formats

Generate ISO‑compatible PDFs and Excel summaries that bundle source files, redactions, and a searchable index for reviewers.

Audit Trail Package

Include signer metadata, IP addresses, timestamps, and field change history to prove document integrity and chain of custody.

Attachments

Attach clinical notes, imaging, device identifiers, and batch records; clearly label each file with file date and source.

Version Control

Maintain sequential revisions with author, date, and reason for change to support post‑submission follow‑ups.

Illustrative Use Cases from Healthcare Organizations

These examples show how organizations apply post market surveillance to identify trends and act quickly on safety signals.

Fertility Centers of Illinois

A regional clinic tracked device complaints post‑launch to detect a pattern of failures within specific lots.

The team initiated a targeted investigation.
The documented surveillance record supported a voluntary recall decision and informed updated labeling and distribution hold protocols across affected sites.

Optica Ventures LLC

A small device firm used registry data to confirm a rare adverse event signal over twelve months.

Signal confirmed with external data.
The manufacturer implemented design verification tests, updated instructions for use, and provided a comprehensive surveillance package to regulatory authorities and customers.

Security and Compliance Elements to Include

Encryption In Transit: TLS 1.2/1.3

Encryption At Rest: AES‑256

HIPAA Support: BAA required for PHI handling

Audit Trail: Detailed timestamps and signer metadata

21 CFR Part 11: Support for FDA electronic record requirements

Certifications: SOC 2 Type II, ISO 27001

Key Risks and Consequences of Incomplete Surveillance

Regulatory Action: Inspections, warning letters, or enforcement

Patient Harm: Delayed mitigation can increase safety incidents

Civil Liability: Increased exposure to lawsuits and settlements

Data Breach Fines: HIPAA penalties and state fines possible

Reputational Damage: Loss of trust and market share

Financial Costs: Recall and remediation expenses

Common Preparation Mistakes to Avoid

Incomplete device identification or missing lot numbers that prevent tracing affected units.
Failing to retain source documents and audit trails, which undermines regulatory responses during inspections.
Using inconsistent terminology across reports, making aggregation and signal detection unreliable.
Delaying internal review and documentation, which can increase regulatory and patient safety risk.

How to Update or Revise an Existing Surveillance Record

Maintain change control for any revisions to ensure transparency and traceability of decisions.

01

Identify Change:

Record the reason and initiator for the update.

02

Review:

Have regulatory and clinical teams vet proposed edits.

03

Approve:

Use formal sign‑off with date and role recorded.

04

Version:

Assign a new version number and archive prior version.

05

Notify:

Alert stakeholders and update downstream systems.

06

Retain:

Keep both old and new versions per retention policy.

Key Surveillance Milestones from Detection to Resolution

Track sequential milestones so each event progresses through a documented review and closure process.

01

Initial Intake

Record and acknowledge incoming reports promptly for triage.

02

Preliminary Assessment

Determine seriousness and need for expedited action or reporting.

03

In‑Depth Investigation

Collect additional evidence, perform root cause analysis, and consult clinicians.

04

Closure and Follow‑Up

Implement CAPA, update records, and verify effectiveness of actions.

Timeframes to Keep in Mind for Surveillance Activities

While specific reporting deadlines depend on product type and regulator, consistent internal timelines help ensure timely action and documentation.

Report Intake:

Acknowledge receipt and log within 24–72 hours of submission

Preliminary Review:

Complete an initial assessment within 7–14 days

Full Investigation:

Conclude thorough investigations within a reasonable, documented timeframe

Regulatory Submission:

Submit required reports per applicable regulatory timelines

CAPA Verification:

Verify corrective actions and document outcomes within a planned interval

Notarization and Witness Steps When Authentication Is Required

Most surveillance records do not require notarization, but contracts, affidavits, or legal declarations may. Follow these steps when authentication is needed.

01

Prepare Document

Ensure the document is final and fields are complete before notarization.

02

Identify Signers

Confirm signers' legal names and bring valid ID to the notary.

03

Choose Notarization Type

Select in‑person notarization or Remote Online Notarization (RON) if permitted.

04

Identity Proofing

For RON, provide credential analysis and multi‑factor authentication.

05

Audio‑Visual Session

Record the RON session and retain per state rules if used.

06

Notary Journal

Notary records the act, method, and signer identification details.

07

Witness Requirements

Add required witnesses where a state statute or document mandates them.

08

Store Evidence

Keep notarization records and recordings as part of the retention package.

Who Has Authority to Sign Surveillance Submissions

Regulatory Affairs Lead

Typically signs regulatory submissions and attests to the completeness of the surveillance package; authorized signers should be documented and empowered under company policy, with role and contact details recorded in the quality system.

Medical/Clinical Officer

Signs clinical assessments and safety conclusions where required; clinical signatories should be qualified clinicians or medical officers with documented delegation of authority and access to source clinical data.

eSignature Vendor Pricing Snapshot for Surveillance Workflows

Comparing baseline pricing and a few functional distinctions helps select a platform that meets security and volume needs without relying on dated price stamps.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7‑day free trial	Yes	Yes	Yes	Yes
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 env./user/yr	Varies	Varies	Varies

Frequently Asked Questions About Healthcare Post Market Surveillance

Answers to common questions about scope, legal applicability, digital handling, and recordkeeping for post market surveillance.

Need help? Contact support

When must an event be reported externally?
Reporting obligations depend on product type and regulatory rules; evaluate seriousness and causality and follow applicable FDA or other regulator timelines for reportable events.
Can electronic records and signatures be used?
Yes; electronic records and signatures are generally enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided intent, consent, attribution, and retention requirements are met.
How should PHI be protected in surveillance data?
Treat protected health information under HIPAA controls, implement BAAs when vendors handle PHI, and apply access controls, encryption, and minimum necessary principles.
Is notarization ever required?
Notarization is rarely required for routine surveillance records but may be needed for legal declarations or affidavits; follow state rules for notarization and RON where used.
What if a record needs correction after submission?
Document revisions with version control and approved change control; notify regulators as required and retain prior versions per retention policy.
How long must surveillance records be retained?
Retention depends on applicable rules; follow HIPAA (45 CFR §164.530(j)) and other federal or contractual requirements and retain records for the longest applicable period.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now